Scrip Asks… What Does 2020 Hold For Biopharma? Part 2: Business And Investment
Innovation Drives Investment But US Election Poses Risk
Executives and analysts predict trends spanning M&A, leadership diversity, curative gene therapy commercialization, biosimilars strategy and more. Expect technology innovation to continue to drive investment and deal making in biopharma.
